Skip to content

Fulgent Genetics, Inc. FLGT Change in Lease Liabilities

Change in Lease Liabilities at other companies

NeoGenomics logo
NeoGenomicsNEO
-$1.3M-19.2%
Natera, Inc. logo
Natera, Inc.NTRA
-$5.85M-29.9%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-$3.58M-32.8%
Veracyte logo
VeracyteVCYT
-$319K+44.7%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s change in lease liabilities?
Fulgent Genetics, Inc. (FLGT) reported change in lease liabilities of -$381K in Q1 2026.
How has Fulgent Genetics, Inc.'s change in lease liabilities changed year-over-year?
Fulgent Genetics, Inc.'s change in lease liabilities decreased by 7.6% year-over-year, from -$354K to -$381K.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.